Found: 9
Select item for more details and to access through your institution.
Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
- Published in:
- Pharmacology Research & Perspectives, 2023, v. 11, n. 3, p. 1, doi. 10.1002/prp2.1072
- By:
- Publication type:
- Article
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19572
- By:
- Publication type:
- Article
Practices in research, surveillance and control of neglected tropical diseases by One Health approaches: A survey targeting scientists from French-speaking countries.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 3, p. 1, doi. 10.1371/journal.pntd.0009246
- By:
- Publication type:
- Article
Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial).
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1930, doi. 10.1111/bcp.14586
- By:
- Publication type:
- Article
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Motochondrial DNA Variant 11719G Is a Marker for the mtDNA Haplogroup Cluster HV.
- Published in:
- Human Biology, 2000, v. 72, n. 6, p. 1065
- By:
- Publication type:
- Article
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article